237 related articles for article (PubMed ID: 20237219)
1. Uncertainty in assessing value of oncology treatments.
Mullins CD; Montgomery R; Tunis S
Oncologist; 2010; 15 Suppl 1():58-64. PubMed ID: 20237219
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
4. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
6. Accelerated approval of oncology products: the food and drug administration experience.
Johnson JR; Ning YM; Farrell A; Justice R; Keegan P; Pazdur R
J Natl Cancer Inst; 2011 Apr; 103(8):636-44. PubMed ID: 21422403
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
Rizzo JD
Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer.
Mullins CD; Montgomery R; Abernethy AP; Hussain A; Pearson SD; Tunis S;
J Clin Oncol; 2012 Feb; 30(6):661-6. PubMed ID: 22253467
[TBL] [Abstract][Full Text] [Related]
9. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
11. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
12. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
13. Communicating the uncertainty of harms and benefits of medical interventions.
Politi MC; Han PK; Col NF
Med Decis Making; 2007; 27(5):681-95. PubMed ID: 17873256
[TBL] [Abstract][Full Text] [Related]
14. Drug pricing and value in oncology.
Danzon PM; Taylor E
Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
[TBL] [Abstract][Full Text] [Related]
15. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice.
McNair AG; Blazeby JM
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):559-67. PubMed ID: 19941433
[TBL] [Abstract][Full Text] [Related]
18. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.
Wright JR; Whelan TJ; Schiff S; Dubois S; Crooks D; Haines PT; DeRosa D; Roberts RS; Gafni A; Pritchard K; Levine MN
J Clin Oncol; 2004 Nov; 22(21):4312-8. PubMed ID: 15514372
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
Manchikanti L
Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
[TBL] [Abstract][Full Text] [Related]
20. Value of information on preference heterogeneity and individualized care.
Basu A; Meltzer D
Med Decis Making; 2007; 27(2):112-27. PubMed ID: 17409362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
